We are live on ! Find out more
SCMP

Sucampo Pharmaceuticals, Inc.
SCMP

Delisted

SCMP was delisted on the 12th of February, 2018.

68 hedge funds and large institutions have $54.8M invested in Sucampo Pharmaceuticals, Inc. in 2013 Q2 according to their latest regulatory filings, with 68 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more call options, than puts

Call options by funds: $19K | Put options by funds: $7K

Holders
68
Holders Change
+68
Holders Change %
% of All Funds
2.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
68
Increased
Reduced
Closed
Calls
$19K
Puts
$7K
Net Calls
+$12K
Net Calls Change
+$12K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

SCMP Hedge Fund Activity: Q2 2013 in Review

68 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Sucampo Pharmaceuticals, Inc. (SCMP) for Q2 2013, worth a combined $54.8M.

Buyers outnumbered sellers: 68 funds opened new SCMP positions and 0 closed out — a net gain of 68 holders — while 0 added to existing stakes and 0 trimmed.

  • 68 institutional investors held Sucampo Pharmaceuticals, Inc. (SCMP) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $54.8M of Sucampo Pharmaceuticals, Inc. stock for Q2 2013.
  • 68 funds opened new Sucampo Pharmaceuticals, Inc. positions in Q2 2013 and 0 closed out, a net change of +68 holders.

Based on aggregated 13F filings for Q2 2013.